An observational study in Hypoxia and Hyperoxia, sponsored by Zonguldak Bulent Ecevit University. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-27.
Sponsored by Zonguldak Bulent Ecevit University · Observational
The study aimed to evaluate different preoxygenation methods (tidal volume for 3 minutes and 4 deep breaths) in pregnant women with oxygen reserve index (ORI).
After the routine monitoring of healthy ASA II pregnant patients between the ages of 18-45, different preoxygenation methods will be applied, and the oxygen status of the patients will be compared with ORI monitoring.
1,231 studies on the registry are indexed under Hypoxia; 241 are open to participants now.
This study's enrollment of 1 is below the median of 67 across 335 observational studies indexed under Hypoxia.
Browse Hypoxia studies →Zonguldak Bulent Ecevit University is the lead sponsor of 96 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients aged 18-45 who had cesarean section under general anesthesia
Exclusion Criteria:
Preoxygenation with 100% oxygen for 3 minutes
Device: Oxygen Reserve Index
4 deep breaths with 100% oxygen in 30 seconds
Device: Oxygen Reserve Index
It is a new non-invasive and continuous measurement parameter that aims to provide information about the oxygen status of patients in the moderately hyperoxic range (100 mmHg\< PaO2 ≤ 200 mmHg).
Preoxygenation Methods
Effects of Different Preoxygenation Methods on SaO2, FiO2 and FeO2 with Oxygen Reserve Index
Time frame: During the surgery
Plan to share: Yes
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zonguldak Bulent Ecevit University